Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of Norepinephrine and Phenylephrine for Postspinal Hypotension
NCT06158009Unknown
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Apr 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
Trial of norepinephrine and phenylephrine in hypotension (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Effective Dose 50 and Effective Dose 90. Status: unknown.
02
Drugs
norepinephrinephenylephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT06158009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06158009.